A detailed history of Swedbank Ab transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Swedbank Ab holds 3,139,552 shares of BMY stock, worth $177 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,139,552
Previous 3,111,125 0.91%
Holding current value
$177 Million
Previous $129 Million 25.75%
% of portfolio
0.21%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$39.66 - $51.75 $1.13 Million - $1.47 Million
28,427 Added 0.91%
3,139,552 $162 Million
Q2 2024

Jul 18, 2024

BUY
$40.25 - $52.99 $125 Million - $165 Million
3,111,125 New
3,111,125 $129 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $140 Million - $159 Million
2,917,639 New
2,917,639 $158 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.